Navigation Links
DSM's Marcel Lubben to Keynote SCD-iBIO's Second International Forum
Date:9/10/2013

WASHINGTON, Sept. 10, 2013 /PRNewswire-USNewswire/ -- SCD-iBIO, an industrial biotechnology group associated with the Society of Chemical Manufacturers and Affiliates (SOCMA), today announced that DSM's Vice President of Bio-based Chemicals & Materials, Dr. Marcel Lubben, will be the keynote speaker at its Second International Forum on Commercializing Global Green: Markets from the Value Chain Perspective. The event will be held November 11-13, 2013, at the Chemical Heritage Foundation (CHF) in Philadelphia, PA.

As a member of the DSM team since 1994, Lubben is responsible for the global activities of the company's Bio-Based Chemicals & Materials business – a group that brings together several global innovation teams focused on developing and commercializing renewable chemicals and downstream compounds. Lubben also serves as a board member of Reverdia, a large-scale facility for the commercial production of biobased succinic acid, which is a joint venture between DSM and Roquette.

"We are slowly, but certainly, starting the switch from a fossil-based to a bio-based economy," said Lubben. "Still at an early stage, it is clear there is no such thing as a silver bullet approach to force your way in. At DSM we believe that a profound understanding of the value chain and the integral relationship between biomass, products and applications are the most important keys to success in this emerging industry."

DSM is a leader in the chemical industry sector in the Dow Jones Sustainability World Index and believes sustainability is about more than compliance and social responsibility. DSM has made sustainability a business driver for the company based on its core values.

"With the knowledge and expertise Dr. Lubben has gained as a leader in the biotechnology industry and as part of the DSM team, he is one of the few people in his field who is in a position to know where industrial biotechnology is today and where it can go in the future," said Larry Drumm, SCD-iBIO's Executive Director. "We are honored to have Dr. Lubben share his insight and perspective on the future of our industry during our International Forum."

The Second International Forum is a three-day interactive event focusing on markets from the value chain perspective. End markets like packaging, automotive, aviation and personal care will be explored, as well as intermediate markets like composites, coatings and adhesives. Sponsors for this year's event include the American Chemical Society, Advanced Biofuels Association, BRAG, Bergeson & Campbell PC, Chemical & Engineering News, AIChE, Adhesive and Sealant Council, BioChemInsights, Inc., CHF and SOCMA.

About SCD-iBIO
SCD-iBIO, an affiliate of SOCMA, is a company member organization that advances the commercial development of industrial biotechnology, which is the application of biology for the environmentally friendly and economically sustainable production and processing of chemicals, pharmaceuticals, materials and energy. www.SCD-iBIO.org

Contact:
Jenny Gaines
Manager, Public Relations & Media
(202) 721-4123
gainesj@socma.com


'/>"/>
SOURCE SCD-iBIO
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Clinical Genomics & Informatics Europe Announce New Keynotes & Final Program
2. U.S. Department of Health and Human Services Deputy Secretary to Present Keynote Address at Conference Hosted by DIA and NORD
3. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9
4. Scientific Luminaries to Keynote at 3rd Annual PODD
5. Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit
6. Dr. Ben Goldacre to Keynote PhUSE Annual Conference
7. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
8. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
9. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
10. SCD-iBIO Announces Second International Forum on Commercializing Global Green
11. SPO Reports Results for Second Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... a new agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate ... and Singapore in the latest adipose and bone marrow therapies. , Through ...
(Date:2/9/2016)... ... , ... Date and time: March 1, 2016, 5:30 p.m. ... Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902. , The ... open house for participants to learn about a new Master of Biomedical Science ...
(Date:2/9/2016)... CA (PRWEB) , ... February 09, 2016 , ... ... strategic changes over the years and Open Access publishing is one of the ... With its 700+ open access journals and 3000+ International Conferences ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of ... in Life-Changing Camp Experiences ... affect the lives of children born with rare diseases, as well ... ) is announcing a new initiative designed to positively affect the ... future of rare disease care. --> To mark the ...
Breaking Biology Technology:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
Breaking Biology News(10 mins):